Naked Scientists: Oxford Malaria Vaccine WHOApproval, Nobel Prize Highlights, and Fear Ecology in Kruger

Podcast at a glance

The Naked Scientists explore a major malaria vaccine development from Oxford that WHO has recommended for large scale production, compare it with an existing malaria vaccine, and discuss trial results. The episode also covers recent Nobel Prizes in physics, chemistry, and medicine, a scientific assessment of Japan’s Fukushima treated wastewater release, and a study from Kruger National Park on how human presence affects wildlife behavior. A Question of the Week about speciation closes the show.

• Malaria vaccine from Oxford shows high efficacy in trials and could transform vaccination campaigns in Africa.
• Nobel physics prize explains attosecond light pulses that illuminate electron motion.
• Nobel chemistry prize focuses on quantum dots and their size dependent properties.
• Nobel medicine prize recognizes the development of messenger RNA vaccines and their delivery systems.

Overview of the podcast

The episode presents a roundup of three scientific breakthroughs and notable science news items. It begins with a discussion of a World Health Organization approved malaria vaccine developed by Oxford University. The vaccine uses virus-like particles and an adjuvant to train the immune system to target a key malaria protein. It targets plasmodium falciparum and has shown around 75 percent efficacy in trials among children aged 5 to 36 months. The hosts compare this vaccine with the RTS,S vaccine by GSK, noting that the Oxford version may offer higher protein density on the parasite surface and potential improvements in immune specificity. Deployment is expected mid 2024, with substantial supply capacity to meet demand in Africa. The segment highlights the vaccine's potential to reduce malaria burden substantially, while acknowledging that vivax malaria remains outside its scope and may require separate solutions. The conversation also touches on booster dosing schedules and durability data, which extend to about three years in current datasets, with longer term monitoring planned.

Nobel Prize physics: attoseconds and electron motion

The episode then profiles the Nobel Prize in Physics, awarded to three scientists for creating light pulses short enough to observe electron dynamics in real time. The prize goes to Anne Lullier, Pierre Agostini, and Ferenc Krausz. The explanation centers on attoseconds, the scale needed to capture electron motion around atomic nuclei. The hosts describe how infrared lasers interacting with gas atoms generate higher frequency overtones, enabling ultrafast light pulses that resolve electron positions and movements with extraordinary precision. The discussion emphasizes the significance of being able to image electrons directly, with potential implications for solar energy and material science. Acknowledgment is given to Nottingham University for help interpreting the science.

Nobel Prize chemistry: quantum dots and applications

Next, the podcast profiles the Nobel Prize in Chemistry, focusing on quantum dots. The award recognizes the work of Alexei Ekimov, Louis Brus, and Moungi Bhawendi, who developed methods to synthesize quantum dots with precise, uniform sizes. Quantum dots have widespread implications across displays, photovoltaics, and sensing technologies. The hosts explain that size-dependent quantum effects alter optical properties, enabling tunable emission colors and highly sensitive detectors. The discussion highlights the historical path from early observations of glass coloration to later controlled synthesis of quantum dot systems and their transformative impact on industry and medicine.

Nobel Prize medicine: messenger RNA vaccines

The programme returns to medicine, detailing the Nobel Prize awarded for the development of messenger RNA vaccines, awarded to Katalin Karikó and Drew Weissman. The segment outlines the key scientific breakthrough achieved around 2005: modifying mRNA with chemical components to reduce immune triggering, which allowed mRNA to be delivered safely into cells. The use of lipid nanoparticles for delivery is described as a critical component for vaccine effectiveness. The hosts discuss how this technology underpinned rapid vaccine development during the COVID-19 pandemic and its potential for cancer therapies and other diseases, underscoring the broader implications of mRNA vaccine platforms.

Speciation and the question of the week

In the Question of the Week, Roger Butlin explains speciation as a gradual process that can arise via geographic isolation or divergent selection in different environments. Darwin’s finches exemplify how populations can diverge on islands, while coastal snails demonstrate adaptation to different habitat pressures. The discussion emphasizes that there is rarely a single generation at which a new species can be definitively declared, and underlines the complexity of speciation as a continuum rather than a single event.

Concluding notes

The programme closes with a look at ongoing science, outreach, and engagement work, and invites listeners to share questions for future episodes.